| Description | The extensive list of concepts provides granular detail on injectable methotrexate options, including concentration, dosage volume, delivery method, and brand names.
This value set can be used for various purposes, such as tracking medication use, identifying preferred injection methods, and monitoring adherence to prescribed dosages. |
| Purpose | (Clinical Focus: This value set identifies various injectable forms of methotrexate used in treatment regimens. It includes details on methotrexate concentration, dosage volumes delivered by prefilled syringes and auto-injectors, and brand names of specific products.),(Data Element Scope: This data element captures the specific form and administration details of methotrexate delivered via injection. It specifies the methotrexate concentration (mg/mL), volume injected (mL), delivery method (prefilled syringe or auto-injector), and brand names (e.g., Otrexup, Reditrex) associated with the medication.),(Inclusion Criteria: This value set encompasses a comprehensive range of injectable methotrexate options:
Methotrexate Concentration: Includes various concentrations of methotrexate solutions (e.g., 2.5 mg/mL, 25 mg/mL, 100 mg/mL).
Dosage Volume: Identifies the amount of methotrexate delivered in prefilled syringes and auto-injectors (e.g., 0.4 mL, 1 mL).
Delivery Method: Distinguishes between prefilled syringes and auto-injectors for methotrexate administration.
Brand Names: Captures brand names of commercially available methotrexate injection products (e.g., Otrexup, Reditrex, Emtexate, Maxtrex).),(Exclusion Criteria: This value set excludes methotrexate provided in other forms (e.g., tablets, pills). Additionally, it does not include information on the specific medical conditions being treated with methotrexate.) |
FHIR